In 2010, cancer care was at an inflection point. Targeted therapies were beginning to emerge following the publication of the first detailed analysis of the human genome, and the clinical landscape was on the cusp of change. Foundation Medicine was…
Need help?
Contact usIn 2010, cancer care was at an inflection point. Targeted therapies were beginning to emerge following the publication of the first detailed analysis of the human genome, and the clinical landscape was on the cusp of change. Foundation Medicine was…